COVID-19 severity and outcome in multiple sclerosis: Results of a national, registry-based, matched cohort study

BACKGROUND: Risk factors associated with coronavirus disease 2019 (COVID-19) severity in patients with multiple sclerosis (MS) have been described. Recent improvements in supportive care measures and increased testing capacity may modify the risk of severe COVID-19 outcome in MS patients. This retro...

Descripción completa

Detalles Bibliográficos
Autores principales: Pérez, Carlos A., Zhang, Guo-Qiang, Li, Xiaojin, Huang, Yan, Lincoln, John A., Samudralwar, Rohini D., Gupta, Rajesh K., Lindsey, John W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366056/
https://www.ncbi.nlm.nih.gov/pubmed/34418735
http://dx.doi.org/10.1016/j.msard.2021.103217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366056/
https://www.ncbi.nlm.nih.gov/pubmed/34418735
http://dx.doi.org/10.1016/j.msard.2021.103217

Ejemplares similares